Search Results - "SLACK, Mary P. E"
-
1
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
Published in The Lancet infectious diseases (01-05-2015)“…Summary Background The 13-valent pneumococcal conjugate vaccine (PCV13) protects against key serotypes that increased after routine immunisation with the…”
Get full text
Journal Article -
2
Non-typeable Haemophilus influenzae , an under-recognised pathogen
Published in The Lancet infectious diseases (01-12-2014)“…Summary Non-typeable Haemophilus influenzae (NTHi) is a major cause of mucosal infections such as otitis media, sinusitis, conjunctivitis, and exacerbations of…”
Get full text
Journal Article -
3
Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England
Published in Vaccine (23-07-2014)“…Highlights • In April 2010 PCV7 was replaced by PCV13. • We investigated pneumococcal carriage in children and their household contacts. • Carriage of PCV13…”
Get full text
Journal Article -
4
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
Published in The Lancet infectious diseases (01-10-2011)“…Summary Background The seven-valent pneumococcal conjugate vaccine (PCV7) has reduced vaccine-type (VT) invasive pneumococcal disease but increases in…”
Get full text
Journal Article -
5
Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine
Published in Vaccine (15-11-2011)“…Highlights ► No direct evidence exists for effectiveness of the new serotypes covered by PCV13. ► Efficacy was presumed via a putative serological correlate of…”
Get full text
Journal Article -
6
Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales
Published in PloS one (02-12-2011)“…The 7-valent pneumococcal conjugate vaccine (PCV-7) was introduced in the United Kingdom in 2006 with a 2, 3 and 13 month schedule, and has led to large…”
Get full text
Journal Article -
7
Changes in Molecular Epidemiology of Streptococcus pneumoniae Causing Meningitis following Introduction of Pneumococcal Conjugate Vaccination in England and Wales
Published in Journal of Clinical Microbiology (01-03-2013)“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
8
Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine
Published in Microorganisms (Basel) (01-07-2023)“…Higher valency pneumococcal conjugate vaccines (PCV15 and PCV20) have been developed to address the disease burden of current non-vaccine serotypes. This…”
Get full text
Journal Article -
9
Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection
Published in Pneumonia (25-05-2023)“…Pneumococcal conjugate vaccines (PCVs) provide protection against vaccine-type pneumococcal disease in both children and adults. Growing evidence suggests that…”
Get full text
Journal Article -
10
Invasive Haemophilus influenzae Type b Disease in England and Wales: Who Is at Risk After 2 Decades of Routine Childhood Vaccination?
Published in Clinical infectious diseases (15-12-2013)“…Background. The introduction of the Haemophilus influenzae serotype b (Hib) conjugate vaccine into national immunization has led to rapid and sustained…”
Get full text
Journal Article -
11
Impact of the 7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Infants Younger Than 90 Days in England and Wales
Published in Clinical infectious diseases (01-03-2013)“…Background. Streptococcus pneumoniae is an uncommon but well-recognized cause of invasive bacterial disease in young infants. This study aimed to determine the…”
Get full text
Journal Article -
12
Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine Introduction Into Routine Childhood Immunization in Kenya
Published in JAMA : the journal of the American Medical Association (09-08-2006)“…CONTEXT Haemophilus influenzae type b (Hib) conjugate vaccine is not perceived as a public health priority in Africa because data on Hib disease burden and…”
Get full text
Journal Article -
13
A review of the role of Haemophilus influenzae in community-acquired pneumonia
Published in Pneumonia (01-01-2015)“…In an era when Haemophilus influenzae type b (Hib) conjugate vaccine is widely used, the incidence of Hib as a cause of community-acquired pneumonia (CAP) has…”
Get full text
Journal Article Book Review -
14
Invasive Pneumococcal Disease, Comorbidities, and Polysaccharide Vaccine Use in Children Aged 5–15 Years in England and Wales
Published in Clinical infectious diseases (15-02-2014)“…Background. In the United Kingdom, the 23-valent pneumococcal polysaccharide vaccine (PPV23) is recommended in addition to routine pneumococcal conjugate…”
Get full text
Journal Article -
15
Association between Single-Nucleotide Polymorphisms in Mal/TIRAP and Interleukin-10 Genes and Susceptibility to Invasive Haemophilus influenzae Serotype b Infection in Immunized Children
Published in Clinical infectious diseases (01-10-2010)“…Background. The development of invasive Haemophilus influenzae serotype b (Hib) disease after prior immunization with the Hib conjugate vaccine (ie, Hib…”
Get full text
Journal Article -
16
Long-Term Immunological Follow-Up of Children with Haemophilus influenzae Serotype b Vaccine Failure in the United Kingdom
Published in Clinical infectious diseases (01-08-2009)“…Background. It is not known how long children with Haemophilus influenzae serotype b (Hib) vaccine failure retain protective Hib antibody concentrations after…”
Get full text
Journal Article -
17
Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales
Published in Vaccine (06-11-2012)“…Highlights ► A 23 valent pneumococcal conjugate vaccine campaign for ≥65 year olds in England and Wales is assessed. ► Vaccine effectiveness against invasive…”
Get full text
Journal Article -
18
Risk of Invasive Haemophilus influenzae Infection During Pregnancy and Association With Adverse Fetal Outcomes
Published in JAMA : the journal of the American Medical Association (19-03-2014)“…IMPORTANCE Unencapsulated Haemophilus influenzae frequently causes noninvasive upper respiratory tract infections in children but can also cause invasive…”
Get full text
Journal Article -
19
Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance
Published in Vaccine (30-04-2024)“…•Robust PCV13 effect against 6C invasive disease and carriage in children.•PCV13 effects against 6A and 6C invasive disease in children were nearly…”
Get full text
Journal Article -
20
Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policies
Published in Vaccine (31-08-2023)“…Neither indirect protection through use of 13-valent and 10-valent pneumococcal conjugate vaccines (PCV13 and PCV10) in pediatric National Immunization…”
Get full text
Journal Article